Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MAO A/HDAC-IN-1 is an effective monoamine oxidase A (MAO A) and HDAC dual inhibitor, which can be used for glioma research.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 349,000 |
50 mg | 約10-14 週間 | ¥ 454,500 |
100 mg | 約10-14 週間 | ¥ 574,000 |
説明 | MAO A/HDAC-IN-1 is an effective monoamine oxidase A (MAO A) and HDAC dual inhibitor, which can be used for glioma research. |
In vitro | MAO A/HDAC-IN-1 (compound 15) increases histone H3 and α-tubulin acetylation and induce cell death via nonapoptotic mechanisms [1]. |
In vivo | Compound 15 (MAO A/HDAC-IN-1) decreases tumor size, lowers MAO A activity in both brain and tumor tissues, and extends survival [1]. |
分子量 | 401.89 |
分子式 | C21H24ClN3O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MAO A/HDAC-IN-1 Inhibitor inhibitor inhibit